The world’s first use of the Blu Build Cesium-131 brachytherapy delivery system to treat prostate cancer at Hollings Cancer Center is an important development for prostate cancer patients and their doctors. Here’s the WTAT-TV report.
Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session
The result from first patient dosed with VMT-α-NET in India on a compassionate use basis showed favorable responses. The initial response was...
